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Abstract
Background: Juvenile Dermatomyositis is a rare, potentially life-threatening condition with no known cure.
There is no published literature capturing how children and young people feel about their condition, from
their perspective. This study was therefore unique in that it asked children and young people what is it like
to live with Juvenile Dermatomyositis.
Methods: Data were obtained from fifteen young people with Juvenile Dermatomyositis, between eight and
nineteen years of age from one Paediatric Rheumatology department using audio-recorded interpretive
phenomenology interviews. Data were analyzed phenomenologically, using a process that derives narratives
from transcripts resulting in a collective composite of participants shared experiences, called a ‘phenomenon’.
Results: The overarching metaphor of a rollercoaster captures the phenomenon of living with Juvenile
Dermatomyositis as a young person, with the ups and downs at different time points clearly described by
those interviewed. The five themes plotted on the rollercoaster, began with confusion; followed by feeling
different, being sick, steroidal and scared from the medications; uncertainty; and then ended with acceptance
of the disease over time.
Conclusion: Young people were able to talk about their experiences about having Juvenile Dermatomyositis. Our
findings will aid clinicians in their practice by gaining a deeper understanding of what daily life is like and highlighting
ways to enhance psychosocial functioning. Hopefully, this study and any further resulting studies, will raise
understanding of Juvenile Dermatomyositis worldwide and will encourage health care professionals to better
assess psychosocial needs in the future.
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Background
Juvenile Dermatomyositis (JDM) is a rare, potentially life
threatening, systemic condition of unknown origin, char-
acterized by weakness in proximal muscles and skin
rashes, often involving other systems [1–4]. Weakness is
progressive, which can first become evident with having
difficulty climbing stairs and can become profound, with
children progressing to becoming bed bound, unable to
sit up or roll over and for some, they may even require
nutritional support through feeding tubes [5–7]. In
severe cases, this debilitating condition involves children
and young people (CYP) requiring multiple hospitali-
zations, experiencing extreme muscle pain, requiring
daily physiotherapy and cytotoxic medications to gain
symptom control, and as a result they miss months
of schooling [8–10].
The term ‘psychosocial’, pertaining to both psycho-
logical and social, encompasses a multitude of variables,
such as social and emotional support, mood and anxiety.
Research into psychosocial needs in CYP with JDM is
sparse. One of only two published studies examining
Quality of Life (QoL) in JDM found significantly lower
health related QoL in this group compared to controls
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[11]. The study asked parents of 272 children with JDM
to report their child’s QoL using the Childhood Health
Assessment Questionnaire (C-HAQ). Baseline disability
and longer disease duration were major determinants for
poor well-being at follow up [11]. More recently, in a
study exploring the psychosocial impact of having a
child with JDM, 39 caregivers were asked to complete
questionnaires. Results indicate that children with active
JDM had significant lower QoL and family functioning
compared to normative populations [12]. A major limi-
tation of both these studies was the exclusion of CYP as
research participants. The ‘proxy problem’ of whether
parental proxy reports corroborate with child self-
reports examining QoL has been well described in the
literature [13–15], with the consensus that parents gen-
erally underestimate the impact of health-related QoL.
These studies highlight the need to ask children and
young people to report their own QoL and psychosocial
needs. In addition, rather than examining psychosocial
needs from all dimensions, QoL is the main focus re-
ported in the literature following physical health, missing
all the other domains of living with a chronic condition,
such as schooling and emotional adjustment.
Given these gaps in our understanding of the perspec-
tives of CYP with JDM, this study has much to contrib-
ute. The research question this study sought to answer
was: “What is it like to have JDM?”
Study design
Methodology
Phenomenology is both a philosophy and a research
methodology concerned with the ‘lived world’ [16],
comprising different variations and interpretations, pre-
dominantly under two broad headings of Descriptive or
Interpretive. Descriptive phenomenology is guided by
the work of Husserl, its aims are to describe a phenome-
non’s general characteristic rather than the individuals
experiences [17, 18]. Interpretive phenomenology sup-
ported by Heidegger, aims to describe, understand and
interpret phenomenology, put simply as moving from
description to interpretation [17, 19]. Interpretive phe-
nomenology was the methodology of choice for this
qualitative study as the researcher sought to understand
the human experience [20]. This study asked young
people to tell their story of the experience of having
JDM, the researcher then interpreted these stories to
uncover meaning, in order to bring the phenomenon
into the open [21].
Sample and setting
Children and young people were identified from clinic
lists and prospective ward admissions at a specialist
tertiary hospital in London, United Kingdom. The inclu-
sion criteria was any child between the ages of eight and
nineteen years of age with a diagnosis of JDM; only
excluding CYP with any confounding medical condition
which may alter their psychosocial needs, such as
diabetes, however, of note none were excluded.
Methods
Open-ended unstructured interviews allowing partici-
pants to share their experience were used; the method of
choice for phenomenology. However, there is limited
research using phenomenology with CYP as there are
perceived inherent difficulties in encouraging CYP to
freely express their perceptions of their lived experience
without inadvertently directing them. Therefore, partici-
pants were also given the option to use creative methods
in the interview to help them tell their story. Three tech-
niques were used: (1) Body mapping; predominantly
used to illustrate location of pain [22–24], however, due
to its multifaceted nature it allowed CYP to draw or
write their interpretation of how their JDM affects them;
(2) Time-lining; useful to help CYP tell their journey
and allow the participant to decide how much to reveal
[25, 26]; and (3) Comic book design; this was used to
help CYP tell their story in their own style and time
[27–30]. Each of these techniques allowed CYP to reveal
their experience from their developmental understand-
ing and thus reducing the power imbalance, the need for
eye contact and providing a buffer when discussing
sensitive issues such as their feelings about their JDM.
Data collection
Potential participants were approached by a member of
the clinical team when they attended routine clinic ap-
pointments. The first seventeen CYP who were seen in
clinic and met the inclusion criteria were approached to
take part in the study. Parents of two CYP, did not want
to take part when approached, due to work commit-
ments; the remaining fifteen were included in the study.
Recruitment was easier than anticipated as there were
minimal exclusion criteria, and families were eager to
participate. Families chose whether to be interviewed in
the hospital or at home; two parents asked to be present
for the interviews, but they remained in the background.
The audio-recorded interviews were carried out by the
lead researcher (PL). Ten out of fifteen interviewees,
especially the older participants, said they preferred to
talk rather than use creative methods, thus the interview
style was an open-ended, unstructured interview, begin-
ning with ‘tell me about your JDM’. The interviews took
place between August and December 2017.
Data analysis
Audio-recordings were transcribed verbatim by the lead
researcher. The average interview length was an hour,
ranging from 18min to the longest being 130 min. One
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CYP drew their timeline and one drew in the comic
book, with the same aim of describing their journey with
JDM. Three children drew the effects of their disease
upon the body-map outline, see Fig. 1 for an example
from a ten year old. The visual methods were checked
alongside the transcribed interviews to ensure all written
and drawn creations were mentioned verbally.
The aim of interpretive phenomenology is to describe,
understand and interpret experience from those experi-
encing it [17, 19, 31], achieved through a circular
continuous process of reading, writing and talking [32].
A method proposed to derive narratives from transcripts
[33] was modified into clear steps (Table 1). This process
begins with the reading and re-reading of the transcripts,
before removing repetition and superfluous text. As the
process continues; words are added to make the text
readable and finally crafted keeping the data true to its
original meaning whilst showing what the researcher is
interpreting. In this study, this resulted in fifteen narra-
tives, one from each participant. These were then plot-
ted alongside each other looking for shared meaning
within each of the voices. Subsequently, an overarching
phenomena which captured living with JDM was identi-
fied with five shared themes within it, and these themes
were then plotted together as separate narratives to
complete the data analysis. The themes were reviewed as
they developed by both the lead researcher PL and
doctoral supervisor FG: data saturation was felt to be
reached at fifteen interviews.
Rigour and trustworthiness were enhanced by the lead
researcher keeping a reflexive diary, maintaining a clear
audit trail, undertaking a presuppositions interview and
the transcripts and final results were read by two
members of the supervisory team with constant discus-
sion. Two members of the supervisory team are psychol-
ogists, and thus were invaluable in directing, assisting
and supporting the lead researcher throughout the study.
It is worth noting that phenomenology has been cri-
tiqued for its inherent bias, however the findings pre-
sented are always simply the impressions gained, as it
presents someone else’s lived experience [31].
Phenomenology often takes the end results back to the
individual participants to ‘member check’, however, there
was concern that this could cause upset in the young
people when reflecting upon their thoughts about living
with a chronic condition. Therefore, as a compromise,
after data analysis had occurred, it was decided to invite
the young people back as a group to discuss general
themes, all completely anonymised.
Fig. 1 A drawing representing participant’s experience of Juvenile
Dermatomyositis. Children and young people were given the option of
drawing how they view the effects of Juvenile Dermatomyositis on their
body, either as part of the interview (a warm up activity) or if they did
not want to talk, instead of the ‘standard interview’. They were offered a
blank ‘bodymap’ and encouraged to complete however they wanted
to, whether in text or drawing. The young person who completed this
example, explained that they were drawing; the rash on the hands and
face and knees, the biopsy site, the intravenous line in situ, constant
tummy ache, vomit due to the medicines, tablet packets, scales (as they
had lost so much weight) and a chair which they required as they
couldn’t stand. They went on to write on their picture “I could not
move”, “Always feel sad” and a thought bubble showing “I want this
to STOP”
Table 1 Steps of data analysis taken when conducting
interpretive phenomenology, adapted from Caelli [33]
1. Reading and re reading whole interview many times
2. Highlighting the first level extra text which can come out e.g.
interviewer questions or listening noises where not important,
and ‘umms’ and ‘huh’ which are extra
3. With first level text removed
4. Second level coding procedure to identify sections that wander
away from phenomena, are superfluous e.g. when discussing what
they had for lunch or do not make good grammatical English
5. With second level text removed
6. Third level, all of it with added words to make it readable, but
keeping participant words wherever possible
7. Craft into story, in a way that ‘shows’ what the researcher is noticing
and interpreting whilst working with the data and keeping it true to
original meaning
8. With comments added to show initial themes of each paragraph of
crafted story
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Results
Fifteen young people participated in this study (Table 2).
In keeping with phenomenology, characteristics such as
economic status and education level were not collected as
the focus was on individuals own experience of their
unique journey. Individual patient data reported were kept
to a minimum to protect participant anonymity in such a
rare disease. However, two thirds of the young people
interviewed had a chronic disease course lasting longer
than five years in length. The sample was heterogeneous:
length of disease (from three weeks to sixteen years);
severity of disease (from acute inpatients to those in
remission off medication); treatments received; and know-
ledge and support. This diversity was apparent when read-
ing the narratives, however, all progressed through similar
stages at similar times of their disease course.
The researcher (PL) was immediately struck by the
magnitude of the impact of JDM on the equilibrium of
the CYP. To a young child or adolescent who is leading
a normal, healthy and active life; to be suddenly knocked
off balance, almost by something out of nowhere, some-
thing which potentially renders you unable to move, was
hugely significant for all of the participants. It was this
impact, and how this was experienced by individuals that
was being verbalised in these stories. It was more than
just knocking them over, it was the repetition, doing it
again and again, taking them up and dropping them
down. Hence the emergence during data analysis of a
metaphor of a rollercoaster, helped to illustrate this
experience visually. It was then possible to describe
all fifteen stories using this metaphor. For example,
the youngest and very recently diagnosed hospitalised
child in the study had just stepped onto the roll-
ercoaster, experiencing the first bottom dip, whereas
the eighteen year old who had been diagnosed at two
years of age, had come so far on the rollercoaster ride
that now they could not remember what came before.
This overarching phenomena of the rollercoaster, with the
ups and downs associated with the common emotions,
fears and challenges, was a typical journey for all those
interviewed and could be illustrated visually when describ-
ing a journey with JDM (Fig. 2). Within the overarching
phenomena of the rollercoaster there were ‘themes’,
almost encapsulating each step along the way. The themes
expressed as described by the CYP included confusion;
feeling different; sick, steroidal and scared; uncertainty;
and acceptance.
Each of these five themes is presented in turn and
illustrated using a combination of voices from the shared
stories, consequently, unlike other types of qualitative
research, the quotes cannot be identified from one indi-
vidual as some may be from more than one participant.
This anonymity is also essential for the families when
sharing the sensitive words of few young people with a
rare condition.
Confusion
Young people talked about confusion for different reasons.
Even before a diagnosis, participants talked overwhelm-
ingly about this confusion that the JDM seemed to come
out of nowhere and affected them in ways that they found
confusing, especially the impact of losing muscle strength;
“We saw so many doctors, I remember just being so
anxious about what was going on, I didn’t know why
my body wasn’t functioning in the way it should.”
Other reasons mentioned, included confusion that
no one knows what is wrong with them; the confu-
sion that they may be unwell but equally just be
considered lazy; the confusion health care profes-
sionals have in diagnosing them; and the confusion
from their family in trying to support them. Also, the
fear from having a rare, often unknown condition
which required referrals to other specialist centres
was mentioned by a third of the young people. These
are exemplified by the following quotes:
“My GP (General Practitioner) said he didn’t know
what was happening to me, so he referred me to
my local hospital, but they didn’t know what was
wrong with me.”
One of the young people talked about the speed of
onset in her particular case:
“At the beginning, I just started as a normal 10 year
old being able to do cross country with my class and
then suddenly I woke up and I wasn't able to do
anything and I think it’s how quickly it happens.”
Confusion also occurred when there was a lack of
understanding, amplified if those around you, for
Table 2 Demographic details of study participants
Gender 6 males, 9 females
Ethnicity 12 White British, 3 other
Age at interview 8–18 years (median 12 years, 7 were 8-12 yrs., 8
were 13-19 yrs)
Age diagnosed 2–16 years (median 8 years)
Disease duration 3 weeks – 16 years (median 5 years)
Disease severity From acutely unwell in-patients, to in remission,
off medicines
Disease course 10 chronic, 4 monocyclic, 1 polycyclic
Medications received 15 had received Methotrexate, 7 had Anti-TNF
Treatment
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example health care professionals, teachers and
parents are also confused, and this was most apparent
at diagnosis and hence placed at the beginning of the
rollercoaster.
Feeling different
Feeling different was striking when reading all the 15
separate narratives. Whilst ‘feeling different’ spanned the
whole rollercoaster, there were specific times when it
was particularly apparent, such as in the beginning when
the young people developed the vivid facial rash as
described here by the following quote:
“I hated the way that I looked so I wouldn’t leave the
house without make up on. My face was literally bright
red and swollen, and I just looked horrible, like a
baboons bum.”
All of the CYP who had JDM diagnosed at a younger
age raised the noticeable differences that it brings in the
beginning, such as the facial rash and gottrons papules;
but all highlighted that as the disease progressed these
often fade and become difficult to see. The majority of
the young people thought this was a negative thing as
they have to keep explaining what is wrong with them;
“JDM is hidden, it’s more inside the body, it’s not like a
visible disability with a wheelchair all the time, so just
because you can’t see it, it doesn’t mean it’s not there.”
The CYP articulated the need to explain what JDM is
and how this makes them different to their peers;
“People don't know what it’s like at all and they've never
heard of the condition before so I have to explain the
same thing 24/7 and it's really irritating to explain all
the time and for no one to understand at all.”
Within this theme, there was also an expression of
clear advantages to being different such as receiving
treats and nominations towards special trips. As one
said;
“It turned out that having the illness has good
moments as well because it’s so rare people took
an interest. I got invited to this party for people
with bad illnesses, so you do feel kind of special.”
Fig. 2 The illustrated Rollercoaster Metaphor. This visual creation was developed after considering the journey which young people were describing. The
downward track in the beginning as they began to get unwell from the Juvenile Dermatomyositis and the confusion from not knowing what is wrong.
Then some relief and a journey up the rollercoaster as they finally get a diagnosis and a name for their symptoms, something which they can research
and tell family and friends. This is followed back down the track as the realisation that it can be a serious condition, often at this stage accompanied by
active, painful disease as they wait for treatment therapies to begin. Then back up the track as the treatments have started and they begin to feel better,
maybe become able to move more and regain some strength. The rollercoaster continues like this as each young person described the seesaw of
emotions, feelings and symptoms as they travelled on their JDM journey. The rollercoaster ride can go on for many years, with young people having ups,
downs and plateaus from day to day and month to month, even year to year. This depiction can be used as it is shown, or modified to meets the needs
of individual children, young people and their families in clinic to illustrate the rollercoaster and to help alleviate some of the unpredictability, confusion
and increase their knowledge and understanding; preparing them for the future
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Sick, steroidal and scared
Captured in this theme was the concerns expressed
by young people when discussing their medications
they had to take, and the resulting effects. One
teenager used the term “steroidal” specifically when
talking about the effects caused by the steroids;
others openly talked about their nausea and sickness
caused by the methotrexate; the ‘scared’ emotion was
expressed when describing the methotrexate injec-
tions and not knowing how they might feel during
the subsequent days, often anticipating the worst.
The effects of the medications were mentioned
always in a negative manner, especially methotrexate
as exemplified by this quote:
“I’d feel sick before I even had it, then I started almost
throwing up when I was having the injection, and having
a panic attack before it because the day afterwards, no
matter what I did, I would feel sick, and just wanting to
cry because I just felt so horrible.”
Fear from the methotrexate; both unpredictable side
effects and the needles themselves were discussed;
“My mum would bring it in, I’d sit there being
like, ‘No,’ shaking, and she’d swipe my leg (with an
alcohol wipe), and then I’d literally be grabbing
onto her arm, and she’d have to just do it as
quickly as she could, and I’d just cry. So this
became a routine thing on a Friday, which is
obviously not the best way to spend your Friday
nights. All my friends are out, and I’m sitting in
bed crying.”
Steroids are known to cause weight gain, stretch
marks and a cushingoid face. They are often used in
JDM to reduce inflammation in the beginning and at
times of disease flare, and especially to the adoles-
cents in this study; they had a huge psychosocial im-
pact that featured in their stories;
“My appearance really changed as I noticed my face
went very red at the time, I had the round chubby
moon face, most of my body put weight on and I
became hairier. I was thinking, ‘I’m getting uglier.’”
Uncertainty
All the young people talked very clearly about uncer-
tainty about their JDM, not only their own uncer-
tainty but also that of others;
“The teachers told them I'm allergic to the sun which
isn't actually true, because she doesn’t understand
either, I don’t think any of the school teachers know
about it.”
There was uncertainty about why they were unwell,
uncertainty with the day-to-day effects, the relapsing
and remitting nature of the disease, uncertainty about
the future and about the effects JDM had on them, as
this quote highlights;
“When I went home from the hospital, my parents
moved all my stuff downstairs so that my room was in
what was my dad's office. You know the feeling when
you're on a holiday but it is raining and you feel a bit
miserable? It was like that because you didn’t know
what was happening. Everything had literally just been
thrown off balance and it was scary.”
For example, one of the ten year olds in the study,
articulated that because there was no cure, no one can
know what is going to happen, again highlighting the
impact uncertainty can have.
Acceptance
During the interviews, half of the CYP expressed ‘a
degree of needing to get on with life’, and as one
described it, ‘accept JDM for what it is, because you can’t
change it’. Whilst the majority who talked more
frequently about accepting their condition, had by their
own admission ‘less active JDM now’, even those who
were in hospital for treatment or experiencing disease
flares, had a level of maturity and degree of acceptance
to their disease as this thirteen year old explains;
“I still say to myself that I'm going to get better either
way, like it may take longer than other people, may be
shorter or just the same, but I know eventually I will
get better.”
Some young people talked about how they feel their
JDM has changed their view on life, as this quote
illustrates;
“My JDM has made me a better person, I used to be
very negative and now I'm positive. I embrace my
JDM and I feel more powerful that I have it, I just feel
good that I had it as it has taught me a lot of things.”
Resilience was evident within the discussions; whilst
CYP openly talked about how things have been hard,
they equally wanted to share the importance of getting
on with life;
“You get over it, because you don’t have a choice,
that’s the thing that I learnt fairly quickly, that it’s fine
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to be sad about it, but if you’re going to sit there and
be sad about it, you’re going to let it stop you living
your life, because it’s not going to go away.”
Discussion
This study invited children and young people to share
their experience of living with JDM. Those participat-
ing had a range of disease durations, disease severities
and unique experiences. However, there were marked
similarities in the stories they told and this was
captured through the phenomenon of a rollercoaster.
Feeling different, sick, steroidal and scared and having
uncertainty were themes which spanned the whole of
the rollercoaster, but would be more prominent at
different time points depending on what else was
happening to the young person in their life; whether
due to their JDM, such as disease flares, or socially,
such as changing schools. There was also some over-
lap between these themes. For example a statement
on the effects of medications, could equally fit into
feeling different, or sick, steroidal and scared. How-
ever, the rollercoaster does not imply a linear process
ending in acceptance. The six CYP who were inter-
viewed and who later attended a follow up session to
hear and discuss the themes and rollercoaster meta-
phor, agreed that acceptance of JDM and the limita-
tions and challenges it brings is a helpful place to get
too, but may not be sustainable or appropriate for all
children and young people.
The ups and downs which illustrated the journey CYP
with JDM talked about, have obvious commonalities
with other chronic illnesses. The rollercoaster metaphor
has been used previously in the literature to describe
other health events such as people acquiring a physical
impairment in youth ‘The Rollercoaster Ride’ [34],
becoming the parent of a deaf child ‘The roller-coaster
of experiences’ [35], and ‘Rollercoaster Asthma’ [36].
Looking specifically at other paediatric auto-immune
conditions, the study by Gomez-Ramirez (2016) de-
scribes parents journeys when caring for their children
with juvenile arthritis as akin to the recurring ups and
downs of rollercoaster rides, with parents feeling an
underlying anxiety [37], which mirrored some findings
in this study. A further study in juvenile arthritis, this
time in the young people themselves, report similar
themes, such as those of aversion to being different and
suspension in uncertainty. However, there are JDM spe-
cific elements which have emerged out of this study, and
whilst they individually have similarities with other
health conditions, the impact of putting these together
constitutes the lived experience of JDM. As evidenced
through the quotes, these included the difficulty in diag-
nosis due to its rarity; the speed of onset; the impact of
losing muscle strength and potential inability to move;
the constant need to explain what the condition is; the
invisibility over time; the remitting nature; and lack of a
cure. Due to the lack of research, it is not possible yet to
compare the psychological impact of JDM compared to
other chronic illnesses, but this research is ongoing.
Juvenile Dermatomyositis is a rare condition typically
managed in specialist centres around the world. The
physical effects of JDM are often presented in the litera-
ture [4, 38–40], but this study brings attention to the
psychosocial issues. Any ‘tools’ which health profes-
sionals employ to measure physical disease status only
capture half the picture of how CYP with JDM are really
doing. Currently there are no instruments available
specifically to assess psychosocial needs of those with
JDM, however work is ongoing in this area and the
development and dissemination of these will be very
valuable to the speciality. Not all treatment centres will
have a psychologist or specialist nurse to support young
people in their day to day management of their condi-
tion, therefore, having an understanding of the psycho-
social effects upon CYP of chronic disease in general,
and more specifically of JDM, is important for all.
Screening for concerns, such as low mood and anxiety is
a good place to start and has been shown by Knight
(2018) to be vital in young people with Lupus, a similar
rheumatic condition [41]. Through providing more
developmentally appropriate information on a regular
basis and providing an opportunity for young people to
voice their anxieties is essential. Furthermore, providing
strategies to help CYP manage the inevitable uncertainty
of living with an unpredictable chronic condition; ensur-
ing they are assisted to explain their condition in a clear
and concise way to their peers and frequent information
is given to schools, is recommended. The young people
interviewed talked about a lack of knowledge and under-
standing from their teachers about JDM, and whilst this
could apply to other rheumatic conditions, we believe
there is no published literature for health care profes-
sionals or parents to provide to schools, unlike other
conditions such as Juvenile Idiopathic Arthritis (JIA).
Whilst there is limited research within the JDM special-
ity field, there is extensive progress made through over
conditions such as oncology, but also within similar
autoimmune conditions like juvenile arthritis. For ex-
ample, these areas of need could be filled by provision of
targeted psychosocial interventions, which could include
one-to-one counselling or peer support disseminated
through a peer mentoring system as described by Kohut
et al. (2018) for juvenile arthritis [42].
Having an understanding of the rollercoaster as a
metaphor in clinical practice could be helpful to aid cli-
nicians when talking to the CYP and their family about
where the young person feels they are. For example, a
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young child who is struggling, may be able to point at
the bottom of the rollercoaster without the need to
articulate verbally how they are feeling. Similarly, it can
help physicians to discuss certain emotions at more
appropriate time points in their care, such as not talking
about acceptance, when they are still struggling with
confusion. Ultimately, the simplicity of the rollercoaster
metaphor is one which can be used clinically to highlight
to CYP and their families the turbulent nature of their
disease and the path they may follow, whilst scaffolding
the specific requirements for CYP to get them to the top
of the track, thus reducing some of the inherent confu-
sion around having JDM.
Limitations
Qualitative studies are small in number of participants,
and rich in depth. These CYP were all recruited through
one institution and therefore their stories may be differ-
ent to others who experience other treatments or
comorbidities. Asking CYP to talk openly about sensitive
topics such as their health, is known to be challenging,
but through the addition of creative methods in this
study, this made it easier for some. In phenomenology
studies, demographic diversity is not prioritised, instead
the purpose is to bring various voices to the study, not
to compare difference [43]; however, although low, there
was a range of disease duration, severity, treatments and
age of participants. Whilst the rollercoaster metaphor is
likely to be ongoing and adaptive to changes over time,
unfortunately due to the cross sectional design of the
study this cannot be explored further, longitudinal re-
search is therefore required.
Conclusions
Better assessment of mental and psychosocial health in
children and young people is firmly on the political
agenda for both Europe [44] and England [45], however,
this is the first study to ask CYP what it is like to live with
JDM and thus provides a starting point for health care
professionals to work from. Further research is underway
to establish whether the concerns raised in this study are
typical of the severity of patients we see in this tertiary
centre or indeed whether they are shared with a larger UK
wide population of CYP with JDM. Together the results of
these two linked studies have the potential to improve
practice by developing targeted interventions to address
psychosocial need in the future. After all, as the CURE JM
website states “Whether the course of the disease is mild
or severe, Juvenile Myositis is life changing for all of these
children and their families” [46].
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